Last viewed:
AZN
Prices are updated after-hours
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
(0.0% 1d)
(7.3% 1m)
(-3.3% 1y)
(0.0% 2d)
(1.1% 3d)
(3.9% 7d)
(Infinity%
volume)
Earnings Calendar:
Market Cap: $ 220,674,000,347
http://astrazeneca.com
Sec
Filling
|
Patents
| 70600 employees
AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
cardiovascular
respiratory
urea
renal
metabolic
add to watch list
Paper trade
email alert is off
Press-releases
Angle PLC Announces New Commercial Agreement with AstraZeneca
Published: 2024-04-24
(Crawled : 09:00)
- biospace.com/
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
| -3.53%
| O: -3.53%
H: 0.0%
C: 0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
| 1.12%
| O: 1.42%
H: 0.08%
C: -0.29%
astrazeneca
commercial
agreement
Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22
(Crawled : 22:00)
- prnewswire.com
RBGPF
|
News
|
$52.06
6.46%
4.8K
|
Consumer Non-Durables
| 3.61%
| O: 0.98%
H: 5.46%
C: -0.89%
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
| -2.22%
| O: -3.15%
H: 0.0%
C: -0.61%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
| -2.44%
| O: 0.96%
H: 2.38%
C: 0.17%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
| 0.94%
| O: 1.69%
H: 0.02%
C: -0.74%
RBGLY
|
News
|
$10.59
-2.05%
850K
|
Manufacturing
| 3.68%
| O: -0.28%
H: 2.18%
C: 1.99%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
| 3.78%
| O: 4.32%
H: 0.0%
C: 0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
| 0.67%
| O: 0.17%
H: 1.48%
C: 1.43%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
| -0.17%
| O: 0.56%
H: 0.41%
C: -0.07%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
| 2.53%
| O: 1.7%
H: 0.0%
C: 0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
| 1.53%
| O: 0.4%
H: 0.0%
C: 0.0%
drug
astrazeneca
set
key
therapeutics
market
Mass Notification Systems Market size is set to grow by USD 16.67 billion from 2023-2027, Alert Media Inc., Alertus Technologies LLC and American Signal Corp., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22
(Crawled : 22:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
| -2.44%
| O: 0.96%
H: 2.38%
C: 0.17%
JCI
|
News
S
|
$64.61
-0.86%
0.0%
7.3M
|
Producer Manufacturing
| 0.64%
| O: 0.32%
H: 0.93%
C: 0.49%
HON
|
News
4
|
$194.72
-0.73%
-0.74%
3.4M
|
Producer Manufacturing
| -1.02%
| O: 0.23%
H: 0.81%
C: 0.07%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
| -0.17%
| O: 0.56%
H: 0.41%
C: -0.07%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
| 1.53%
| O: 0.4%
H: 0.0%
C: 0.0%
media
alert
set
key
market
Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19
(Crawled : 15:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
| 0.03%
| O: 0.24%
H: 0.42%
C: 0.42%
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
| 1.31%
| O: -0.84%
H: 0.86%
C: -0.62%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
| 3.18%
| O: -0.56%
H: 0.0%
C: 0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
| -2.47%
| O: -0.21%
H: 0.11%
C: -3.05%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
| 4.3%
| O: -0.18%
H: 0.84%
C: 0.6%
report
reach
therapeutics
market
Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials
Published: 2024-04-16
(Crawled : 14:00)
- biospace.com/
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
| 3.59%
| O: -0.64%
H: 0.45%
C: -0.04%
million
series
trials
program
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
| 1.11%
| O: -1.75%
H: 0.85%
C: 0.85%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
| -0.43%
| O: 2.1%
H: 0.0%
C: -2.52%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
| 4.41%
| O: -1.46%
H: 0.0%
C: 0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
| 0.89%
| O: -1.19%
H: 0.52%
C: -0.17%
BAX
|
$40.93
-0.22%
0.0%
2.2M
|
Health Technology
| 2.22%
| O: -0.1%
H: 0.13%
C: -1.08%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
| 3.79%
| O: 0.32%
H: 0.96%
C: 0.22%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
| 1.23%
| O: -2.13%
H: 0.0%
C: 0.0%
BMRN
|
$91.25
-0.88%
-0.89%
1.6M
|
Health Technology
| 0.68%
| O: -0.72%
H: 0.0%
C: 0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
| 3.59%
| O: -0.64%
H: 0.45%
C: -0.04%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
| 2.82%
| O: 0.41%
H: 0.0%
C: 0.0%
set
therapeutics
market
FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Published: 2024-04-11
(Crawled : 12:00)
- biospace.com/
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
| -0.66%
| O: 1.47%
H: 1.16%
C: -1.27%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
| 5.29%
| O: 3.34%
H: 0.27%
C: -0.62%
children
approved
treatment
for
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
| 1.41%
| O: 2.24%
H: 0.0%
C: -0.8%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
| 1.6%
| O: -3.43%
H: 6.21%
C: 6.21%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
| -2.12%
| O: -0.25%
H: 1.1%
C: -0.17%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
| 2.67%
| O: -0.05%
H: 0.43%
C: -0.27%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
| -4.79%
| O: -0.08%
H: 0.04%
C: -0.35%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
| -17.77%
| O: 0.38%
H: 0.0%
C: -7.27%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
| -0.07%
| O: 0.77%
H: 1.63%
C: 0.35%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
| 1.11%
| O: 0.84%
H: 0.0%
C: 0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
| 5.56%
| O: 0.18%
H: 0.3%
C: 0.19%
eczema
dermatitis
set
therapeutics
market
Genome Editing Market size is set to grow by USD 7.23 bn from 2024-2028,rapid technological advancements in genome editing boost the market- Technavio
Published: 2024-04-05
(Crawled : 22:00)
- prnewswire.com
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
| Email alert
Add to watchlist
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
| Email alert
Add to watchlist
CRBU
|
$3.86
-3.02%
-3.11%
1.1M
|
Health Technology
| Email alert
Add to watchlist
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
| Email alert
Add to watchlist
set
market
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
Published: 2024-04-02
(Crawled : 08:00)
- biospace.com/
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
| 4.78%
| O: -1.18%
H: 0.34%
C: -0.22%
breast
her2
license
cancer
application
negative
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount